State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009–2020
Journal of the American Medical Informatics Association · 2024
DOI: 10.1093/jamia/ocae160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, 2024. Verfasst von Christian E Johnson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, United States. Hauptthemen laut MEDLINE: Prescription Drug Monitoring Programs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Prescription drug monitoring programs (PDMPs) have been widely adopted as a tool to address the prescription opioid epidemic in the United States. PDMP integration and mandatory use policies are 2 approaches states have implemented to increase use of PDMPs by prescribers. While the effectiveness of these approaches is mixed, it is unclear what factors motivated states to implement them. This study examines whether opioid dispensing, adverse health outcomes, or other non–health-related factors motivated implementation of these PDMP approaches.
Methods
Time-to-event analysis was performed using lagged state-year covariates to reflect values from the year prior. Extended Cox regression estimated the association of states’ rates of opioid dispensing, prescription opioid overdose deaths, and neonatal opioid withdrawal syndrome with implementation of PDMP integration and mandatory use policies from 2009 to 2020, controlling for demographic and economic factors, state government and political factors, and prior opioid policies.
Results
In our main model, prior opioid dispensing (HR 2.31, 95% CI 1.17, 4.57), neonatal opioid withdrawal syndrome hospitalizations (HR 1.55, 95% CI 1.09, 2.19), and number of prior opioid policies (HR 2.13, 95% CI 1.13, 4.00) were associated with mandatory use policies. Prior prescription opioid overdose deaths (HR 1.21, 95% CI 1.08, 1.35) were also associated with mandatory use policies in a model that did not include opioid dispensing or neonatal opioid withdrawal syndrome. No study variables were associated with implementation of PDMP integration.
Conclusion
Understanding state-level factors associated with implementing PDMP approaches can provide insights into factors that motivate the adoption of future public health interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, United States.
- Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States.
- Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA 52242, United States.
Zitieren
APA
Johnson, C. E., Chrischilles, E. A., Arndt, S., & Carnahan, R. M. (2024). State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009–2020. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocae160
Vancouver
Johnson CE, Chrischilles EA, Arndt S, Carnahan RM. State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009–2020. Journal of the American Medical Informatics Association. 2024. doi:10.1093/jamia/ocae160
BibTeX
@article{Johnson2024,
author = {Johnson, Christian E and Chrischilles, Elizabeth A and Arndt, Stephan and Carnahan, Ryan M},
title = {State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009–2020},
journal = {Journal of the American Medical Informatics Association},
year = {2024},
doi = {10.1093/jamia/ocae160}
}
EUVIMED